SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
-2.05%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$22.5B
AUM Growth
-$1.23B
(-5.2%)
Cap. Flow
-$526M
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
24.5%
Holding
2,088
New
157
Increased
581
Reduced
721
Closed
155
Top Buys
| 1 |
NVIDIA
NVDA
|
+$46.1M |
| 2 |
Kenvue
KVUE
|
+$43.4M |
| 3 |
Ventas
VTR
|
+$41.9M |
| 4 |
M&T Bank
MTB
|
+$27.4M |
| 5 |
Aon
AON
|
+$24.4M |
Top Sells
| 1 |
Equity Residential
EQR
|
+$34.3M |
| 2 |
Mastercard
MA
|
+$30.1M |
| 3 |
Planet Fitness
PLNT
|
+$28.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$26.6M |
| 5 |
Apple
AAPL
|
+$26.4M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Healthcare | 12.96% |
| 3 | Financials | 12.52% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
AvidXchange
AVDX
$2.06B
| $189K | ﹤0.01% |
20,000
-56,900
| -74% | -$538K |
|
1577
Korn Ferry
KFY
$3.81B
| $189K | ﹤0.01% |
4,000
+3,000
| +300% | +$142K |
|
|
MODV
1578
DELISTED
ModivCare
MODV
| $189K | ﹤0.01% |
6,000
+5,600
| +1,400% | +$176K |
|
1579
Titan International
TWI
$546M
| $189K | ﹤0.01% |
14,100
-19,600
| -58% | -$263K |
|
|
RPT
1580
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $189K | ﹤0.01% |
17,900
| – | – |
|
1581
Genesco
GCO
$355M
| $188K | ﹤0.01% |
6,100
| – | – |
|
1582
Omega Flex
OFLX
$341M
| $188K | ﹤0.01% |
2,400
+800
| +50% | +$62.7K |
|
1583
ADMA Biologics
ADMA
$3.76B
| $184K | ﹤0.01% |
51,400
+20,900
| +69% | +$74.8K |
|
1584
Arlo Technologies
ARLO
$1.77B
| $184K | ﹤0.01% |
17,900
+12,000
| +203% | +$123K |
|
1585
Newmark Group
NMRK
$3.33B
| $184K | ﹤0.01% |
28,700
| – | – |
|
1586
Sierra Bancorp
BSRR
$408M
| $183K | ﹤0.01% |
9,700
-14,700
| -60% | -$277K |
|
|
PGRE
1587
Paramount Group
PGRE
$1.6B
| $183K | ﹤0.01% |
39,700
-46,574
| -54% | -$215K |
|
1588
BridgeBio Pharma
BBIO
$10.1B
| $181K | ﹤0.01% |
+6,900
| New | +$181K |
|
1589
Nuvalent
NUVL
$5.66B
| $179K | ﹤0.01% |
3,900
-6,800
| -64% | -$312K |
|
1590
Cassava Sciences
SAVA
$101M
| $179K | ﹤0.01% |
10,800
-1,900
| -15% | -$31.5K |
|
1591
Universal Technical Institute
UTI
$1.48B
| $178K | ﹤0.01% |
21,300
| – | – |
|
1592
Compass
COMP
$4.83B
| $176K | ﹤0.01% |
60,900
| – | – |
|
1593
Ultrapar
UGP
$4.05B
| $176K | ﹤0.01% |
48,000
| – | – |
|
|
BPMC
1594
DELISTED
Blueprint Medicines
BPMC
| $175K | ﹤0.01% |
3,500
-1,400
| -29% | -$70K |
|
1595
Omnicell
OMCL
$1.46B
| $175K | ﹤0.01% |
3,900
+1,300
| +50% | +$58.3K |
|
1596
Metallus
MTUS
$695M
| $175K | ﹤0.01% |
8,100
-9,500
| -54% | -$205K |
|
1597
Installed Building Products
IBP
$7.21B
| $174K | ﹤0.01% |
1,400
+400
| +40% | +$49.7K |
|
1598
Revolution Medicines
RVMD
$7.56B
| $174K | ﹤0.01% |
6,300
+4,600
| +271% | +$127K |
|
1599
Enanta Pharmaceuticals
ENTA
$178M
| $173K | ﹤0.01% |
15,500
| – | – |
|
1600
BlackLine
BL
$3.32B
| $171K | ﹤0.01% |
3,100
+500
| +19% | +$27.6K |
|